Real-world epidemiology of potassium derangements among chronic cardiovascular, metabolic and renal conditions: a population-based analysis
Autor/a
Jiménez-Marrero, Santiago
Cainzos-Achirica, Miguel
Monterde, David
Garcia-Eroles, Luis
Enjuanes-Grau, Cristina
Yun, Sergi
Garay, Alberto
Moliner, Pedro
Alcoberro, Lidia
Corbella Virós, Xavier
Comin-Colet, Josep
Fecha de publicación
2020-09-11ISSN
1179-1349
Resumen
Background: The aims of the present analysis are to estimate the prevalence of five key chronic cardiovascular, metabolic and renal conditions at the population level, the prevalence of renin–angiotensin–aldosterone system inhibitor (RAASI) medication use and the magnitude of potassium (K+) derangements among RAASI users. Methods and Results: We used data from more than 375,000 individuals, 55 years of age or older, included in the population-based healthcare database of the Catalan Institute of Health between 2015 and 2017. The conditions of interest were chronic heart failure (CHF), chronic kidney disease (CKD), diabetes mellitus, ischemic heart disease and hypertension. RAASI medications included angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, mineralocorticoid receptor antagonists (MRAs) and renin inhibitors. Hyperkalemia was defined as K+ levels > 5.0 mEq/L and hypokalemia as K+ < 3.5 mEq/L. The prevalence of chronic cardiovascular, metabolic and renal conditions was high, and particularly that of hypertension (prevalence ranging from 48.2% to 48.9%). The use of at least one RAASI medication was almost ubiquitous in these patients (75.2– 77.3%). Among RAASI users, the frequency of K+ derangements, mainly of hyperkalemia, was very noticeable (12% overall), particularly in patients with CKD or CHF, elderly individuals and users of MRAs. Hypokalemia was less frequent (1%). Conclusion: The high prevalence of K+ derangements, and particularly hyperkalemia, among RAASI users highlights the real-world relevance of K+ derangements, and the importance of close monitoring and management of K+ levels in routine clinical practice. This is likely to benefit a large number of patients, particularly those at higher risk.
Tipo de documento
Artículo
Versión del documento
Versión publicada
Lengua
English
Materias (CDU)
61 - Medicina
616.1 - Patología del sistema circulatorio, de los vasos sanguíneos. Transtornos cardiovasculares
Palabras clave
Epidemiologia
Potassi
Cardiologia
Insuficiència cardíaca
Sistema cardiovascular -- Malalties
Hipertensió
Epidemiología
Potasio
Cardiología
Insuficiencia cardíaca
Aparato circulatorio -- Enfermedades
Hipertensión
Epidemiology
Potassium
Cardiology
Heart failure
Cardiovascular system -- Diseases
Hypertension
Páginas
12
Publicado por
Dovepress
Colección
12;
Publicado en
Clinical Epidemiology
Citación
Jiménez-Marrero, Santiago; Cainzos-Achirica, Miguel; Monterde, David [et al.]. Real-world epidemiology of potassium derangements among chronic cardiovascular, metabolic and renal conditions: a population-based analysis. Clinical Epidemiology, 2020, 12, p. 941-952. Disponible en: <https://www.dovepress.com/real-world-epidemiology-of-potassium-derangements-among-chronic-cardio-peer-reviewed-article-CLEP>. Fecha de acceso: 27 nov. 2020. DOI: 10.2147/CLEP.S253745.
Este ítem aparece en la(s) siguiente(s) colección(ones)
- Ciències de la Salut [740]
Derechos
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Excepto si se señala otra cosa, la licencia del ítem se describe como https://creativecommons.org/licenses/by-nc/3.0/